Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Decourt

Showing results (11-20 of 49) with videos related to

Pageof 5
Sort By:
Expert Opinion on Investigational Drugs|August 22, 2025
Nonamyloid-beta active immunization for the treatment of Alzheimer's diseaseOlivia Triplett, Nicole Varda, Boris Decourt, et al.
Neurology and Therapy|October 8, 2024
Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 YearsAlexandra Wicker, Jahnavi Shriram, Boris Decourt, et al.
Med (New York, N.Y.)|August 9, 2025
Alzheimer's disease: Clinical trials to watchMarwan Noel Sabbagh, Jessica Kennedy, Jad Majeed, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|October 4, 2008
Is otospiralin inner ear specific? Evidence for its expression in mouse brainBoris Decourt, Dean Hillman, Yohan Bouleau, et al.
Neurology and Therapy|December 25, 2025
Informant-Based Questionnaires in the Diagnostic Pathway for Screening of Cognitive ImpairmentAbarajithan Chandrasekaran, Michael Malek-Ahmadi, Boris Decourt, et al.
Journal of Experimental Pharmacology|November 7, 2022
Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat DementiaBoris Decourt, Keith Noorda, Kevin Noorda, et al.
Journal of Alzheimer'S Disease Reports|November 4, 2024
Biomarker Assessment in Parkinson's Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical MeasuresGiovanni R Malaty, Boris Decourt, Holly A Shill, et al.
Expert Opinion on Investigational Drugs|May 17, 2019
Tau immunotherapies for Alzheimer's diseaseJustin L Hoskin, Marwan Noel Sabbagh, Yazan Al-Hasan, et al.
Neuro-Degenerative Diseases|May 11, 2025
Active immunization targeting amyloid β for the treatment of Alzheimer's diseaseOlivia Triplett, Nicole Varda, Boris Decourt, et al.
Expert Opinion on Investigational Drugs|January 18, 2021
Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MDMarwan Noel Sabbagh, Evans Pope, Laura Cordes, et al.
Pageof 5

Showing results (11-20 of 49) with videos related to

Sort By:
Pageof 5
Expert Opinion on Investigational Drugs|August 22, 2025
Nonamyloid-beta active immunization for the treatment of Alzheimer's diseaseOlivia Triplett, Nicole Varda, Boris Decourt, et al.
Neurology and Therapy|October 8, 2024
Passive Anti-amyloid Beta Monoclonal Antibodies: Lessons Learned over Past 20 YearsAlexandra Wicker, Jahnavi Shriram, Boris Decourt, et al.
Med (New York, N.Y.)|August 9, 2025
Alzheimer's disease: Clinical trials to watchMarwan Noel Sabbagh, Jessica Kennedy, Jad Majeed, et al.
International Journal of Developmental Neuroscience : the Official Journal of the International Society for Developmental Neuroscience|October 4, 2008
Is otospiralin inner ear specific? Evidence for its expression in mouse brainBoris Decourt, Dean Hillman, Yohan Bouleau, et al.
Neurology and Therapy|December 25, 2025
Informant-Based Questionnaires in the Diagnostic Pathway for Screening of Cognitive ImpairmentAbarajithan Chandrasekaran, Michael Malek-Ahmadi, Boris Decourt, et al.
Journal of Experimental Pharmacology|November 7, 2022
Review of Advanced Drug Trials Focusing on the Reduction of Brain Beta-Amyloid to Prevent and Treat DementiaBoris Decourt, Keith Noorda, Kevin Noorda, et al.
Journal of Alzheimer'S Disease Reports|November 4, 2024
Biomarker Assessment in Parkinson's Disease Dementia and Dementia with Lewy Bodies by the Immunomagnetic Reduction Assay and Clinical MeasuresGiovanni R Malaty, Boris Decourt, Holly A Shill, et al.
Expert Opinion on Investigational Drugs|May 17, 2019
Tau immunotherapies for Alzheimer's diseaseJustin L Hoskin, Marwan Noel Sabbagh, Yazan Al-Hasan, et al.
Neuro-Degenerative Diseases|May 11, 2025
Active immunization targeting amyloid β for the treatment of Alzheimer's diseaseOlivia Triplett, Nicole Varda, Boris Decourt, et al.
Expert Opinion on Investigational Drugs|January 18, 2021
Therapeutic considerations for APOE and TOMM40 in Alzheimers disease: A tribute to Allen Roses MDMarwan Noel Sabbagh, Evans Pope, Laura Cordes, et al.
Pageof 5